Medidata Solutions (MDSO) Publishes Revenue Results, Beats Estimates By $0.08 EPS

Medidata Solutions (MDSO) Publishes  Revenue Results, Beats Estimates By $0.08 EPS

Medidata Solutions (NASDAQ:MDSO) released its quarterly earnings data on Tuesday. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.08, MarketWatch Earnings reports. The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $168.08 million. Medidata Solutions had a return on equity of 10.70% and a net margin of 8.43%. The business’s revenue for the quarter was up 18.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.41 EPS. Medidata Solutions updated its FY 2019 guidance to $1.71-1.82 EPS.

Medidata Solutions stock opened at $74.23 on Tuesday. Medidata Solutions has a twelve month low of $60.10 and a twelve month high of $88.87. The company has a quick ratio of 2.52, a current ratio of 2.52 and a debt-to-equity ratio of 0.15. The company has a market cap of $4.48 billion, a price-to-earnings ratio of 87.33, a P/E/G ratio of 4.23 and a beta of 1.32.

A number of research analysts recently issued reports on MDSO shares. Zacks Investment Research downgraded Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 16th. Piper Jaffray Companies dropped their price target on Medidata Solutions from $96.00 to $93.00 in a research note on Thursday, October 18th. Royal Bank of Canada set a $86.00 price target on Medidata Solutions and gave the stock a “buy” rating in a research note on Friday, October 19th. JPMorgan Chase & Co. dropped their price target on Medidata Solutions to $74.00 and set a “neutral” rating on the stock in a research note on Friday, October 19th. Finally, ValuEngine upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $83.73.

In other Medidata Solutions news, CFO Rouven Bergmann sold 12,512 shares of the stock in a transaction that occurred on Wednesday, February 6th. The stock was sold at an average price of $75.00, for a total transaction of $938,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael Pray sold 7,000 shares of the stock in a transaction that occurred on Monday, November 26th. The stock was sold at an average price of $73.02, for a total value of $511,140.00. Following the sale, the executive vice president now directly owns 52,408 shares of the company’s stock, valued at $3,826,832.16. The disclosure for this sale can be found here. Insiders have sold a total of 41,632 shares of company stock valued at $3,126,704 over the last ninety days. 4.70% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of MDSO. Benjamin F. Edwards & Company Inc. lifted its position in Medidata Solutions by 127.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock worth $64,000 after acquiring an additional 529 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in Medidata Solutions during the 4th quarter worth approximately $90,000. Whittier Trust Co. of Nevada Inc. lifted its position in Medidata Solutions by 1,068.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock worth $172,000 after acquiring an additional 2,339 shares during the period. Advisor Group Inc. lifted its position in Medidata Solutions by 27.1% during the 4th quarter. Advisor Group Inc. now owns 2,553 shares of the company’s stock worth $173,000 after acquiring an additional 545 shares during the period. Finally, Stephens Inc. AR lifted its position in Medidata Solutions by 8.7% during the 4th quarter. Stephens Inc. AR now owns 2,722 shares of the company’s stock worth $184,000 after acquiring an additional 218 shares during the period.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Recommended Story: Yield Curve

Related posts

Leave a Comment